Preferred Label : Aripiprazole;
MeSH definition : An antipsychotic agent that is structurally related to piperazines and quinolones.
It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where
it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR,
5-HT2A.; A piperazine and quinolone derivative that is used primarily as an antipsychotic agent.
It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where
it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR,
5-HT2A. It is used for the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER, and as
an adjunct therapy for the treatment of depression.;
MeSH synonym : 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone; Aripiprazol;
CISMeF synonym : 14597, OPC;
MeSH hyponym : OPC 14597; Abilify; OPC-14597;
Wikipedia link : https://en.wikipedia.org/wiki/Aripiprazole;
Is substance : O;
UNII : 82VFR53I78;
Origin ID : D000068180;
UMLS CUI : C0299792;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
An antipsychotic agent that is structurally related to piperazines and quinolones.
It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where
it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR,
5-HT2A.
A piperazine and quinolone derivative that is used primarily as an antipsychotic agent.
It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where
it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR,
5-HT2A. It is used for the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER, and as
an adjunct therapy for the treatment of depression.
https://www.has-sante.fr/jcms/p_3556165/fr/abilify-maintena-aripiprazole-schizophrenie
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
injections, intramuscular
Product containing only aripiprazole in parenteral dose form (medicinal product form)
aripiprazole
adult
antipsychotic agents
evaluation of the transparency committee
schizophrenia
Aripiprazole
---
https://www.has-sante.fr/jcms/p_3361550/fr/abilify-abilify-maintena-aripiprazole-traitement-d-entretien-de-la-schizophrenie
2022
false
false
false
France
insurance, health, reimbursement
treatment outcome
schizophrenia
injections, intramuscular
Aripiprazole
aripiprazole
evaluation of the transparency committee
---
https://www.has-sante.fr/jcms/p_3197834/fr/aripiprazole-arrow
2020
false
false
false
France
French
drugs, generic
evaluation of the transparency committee
Aripiprazole
aripiprazole
pharmaceutical solutions
administration, oral
---
http://www.omedit-aquitaine.fr/sites/omedit.drupal7.aquisante.priv/files/54/fbu_omedit_aripiprazole.pdf
2017
false
true
false
France
French
Aripiprazole
continuity of patient care
drug interactions
administration, oral
aripiprazole
antipsychotic agents
drugs, generic
guidelines for drug use
injections, intramuscular
schizophrenia
manic disorder
adult
manic disorder
recurrence
child
adolescent
bipolar disorder
bipolar disorder
---
https://pharmacomedicale.org/medicaments/par-specialites/item/aripiprazole
2016
false
false
false
France
French
drug information
Aripiprazole
antipsychotic agents
psychotic disorders
Aripiprazole
---
https://minerva-ebp.be/FR/Article/2051
2016
false
false
false
false
Belgium
French
critical appraisal or critical reading
depressive disorder, major
aged
depressive disorder, Treatment-Resistant
Aripiprazole
Aripiprazole
treatment outcome
antipsychotic agents
antipsychotic agents
basal ganglia diseases
randomized controlled trials as topic
middle aged
---
https://www.ema.europa.eu/medicines/human/EPAR/aripiprazole-mylan-pharma-previously-aripiprazole-pharmathen
2015
true
United Kingdom
French
English
syndication feed
drugs, generic
Aripiprazole
Aripiprazole
schizophrenia
treatment outcome
drug evaluation, preclinical
antipsychotic agents
antipsychotic agents
tablets
administration, oral
pregnancy
breast feeding
drug interactions
drug approval
drug labeling
adult
aged
aripiprazole
drug evaluation
summary of product characteristics
package leaflet
---
http://www.has-sante.fr/portail/jcms/c_2038113/fr/abilify-abilify-maintena
2015
true
France
French
secondary prevention
Aripiprazole
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
antipsychotic agents
aripiprazole
treatment outcome
adult
adolescent
schizophrenia
bipolar disorder
bipolar disorder
manic disorder
manic disorder
---
https://www.ema.europa.eu/medicines/human/EPAR/Aripiprazole-Accord
2015
true
United Kingdom
French
English
syndication feed
drugs, generic
Bipolar I disorder
bipolar disorder
europe
Aripiprazole
Aripiprazole
antipsychotic agents
schizophrenia
treatment outcome
drug evaluation, preclinical
antipsychotic agents
administration, oral
pregnancy
breast feeding
drug interactions
drug approval
adult
aged
aripiprazole
drug evaluation
summary of product characteristics
package leaflet
---
Safety information for antipsychotic drug Abilify and risk of certain impulse-control
behaviours
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2015/55668a-fra.php
2015
false
false
false
Canada
French
English
pharmacovigilance note
Disruptive, Impulse Control, and Conduct Disorders
antipsychotic agents
aripiprazole
schizophrenia
bipolar disorder
patients guideline
administration, oral
injections, intramuscular
Pathological Gambling
hypersexuality state
risk
Aripiprazole
---
https://www.ema.europa.eu/medicines/human/EPAR/Aripiprazole-Sandoz
2015
true
false
United Kingdom
French
English
syndication feed
drugs, generic
Aripiprazole
Aripiprazole
schizophrenia
treatment outcome
drug evaluation, preclinical
antipsychotic agents
antipsychotic agents
tablets
administration, oral
pregnancy
breast feeding
drug interactions
drug approval
drug labeling
adult
aged
aripiprazole
drug evaluation
summary of product characteristics
package leaflet
---
http://www.has-sante.fr/portail/jcms/c_1743369/fr/abilify-maintena
2014
false
false
false
France
evaluation of the transparency committee
aripiprazole
antipsychotic agents
schizophrenia
injections, intramuscular
treatment outcome
insurance, health, reimbursement
adult
Delayed-Action preparations
Aripiprazole
---
http://www.cochrane.org/fr/CD006569/aripiprazole-versus-autres-antipsychotiques-atypiques
2014
false
false
false
France
United Kingdom
treatment outcome
comparative study
antipsychotic agents
Atypical antipsychotic (substance)
Aripiprazole
Aripiprazole
meta-analysis
french abstract
schizophrenia
antipsychotic agents
---
http://www.cochrane.org/fr/CD004578
2013
false
true
false
France
United Kingdom
Aripiprazole
treatment outcome
review of literature
french abstract
schizophrenia
---
http://www.cochrane.org/fr/CD005000/laripiprazole-seul-ou-en-combinaison-avec-dautres-medicaments-dans-le-traitement-de-la-manie-aigue-du-trouble-bipolaire
2013
false
false
false
France
United Kingdom
meta-analysis
french abstract
bipolar disorder
acute disease
treatment outcome
drug therapy, combination
antipsychotic agents
antipsychotic agents
Aripiprazole
Aripiprazole
---
http://www.has-sante.fr/portail/jcms/c_1241688/abilify
http://www.has-sante.fr/portail/jcms/c_1701286/fr/abilify
http://www.has-sante.fr/portail/jcms/c_1701285/fr/abilify06112013avisct13116
2013
false
France
French
guidelines for drug use
secondary prevention
Aripiprazole
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
antipsychotic agents
aripiprazole
treatment outcome
adult
adolescent
schizophrenia
bipolar disorder
bipolar disorder
manic disorder
manic disorder
---
https://www.ema.europa.eu/medicines/human/EPAR/Abilify-Maintena
2013
false
United Kingdom
English
French
Aripiprazole
Aripiprazole
drug approval
europe
treatment outcome
aripiprazole
Delayed-Action preparations
schizophrenia
antipsychotic agents
antipsychotic agents
adult
aged
injections, intramuscular
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
summary of product characteristics
package leaflet
syndication feed
---
https://rmlg.uliege.be/article/2377
2012
false
Belgium
French
Duloxetine Hydrochloride
Aripiprazole
depressive disorder, major
journal article
case reports
antidepressive agents
antipsychotic agents
drug therapy, combination
depressive disorder, Treatment-Resistant
chronic disease
---
https://www.ema.europa.eu/medicines/human/EPAR/Abilify
2012
false
United Kingdom
French
English
syndication feed
Aripiprazole
Aripiprazole
schizophrenia
treatment outcome
drug evaluation, preclinical
antipsychotic agents
antipsychotic agents
tablets
administration, oral
pregnancy
breast feeding
drug approval
drug labeling
adult
aged
aripiprazole
drug evaluation
summary of product characteristics
package leaflet
---
http://www.has-sante.fr/portail/jcms/c_1268884/antipsychotiques-de-seconde-generation
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-07/antipsychotiques_14032012_synthese.pdf
2012
false
France
French
guidelines for drug use
evaluation of the transparency committee
Quetiapine Fumarate
Aripiprazole
sulpiride
benzodiazepines
schizophrenia
administration, oral
aripiprazole
treatment outcome
adult
adolescent
clozapine
antipsychotic agents
drugs, generic
risperidone
risperidone
serotonin antagonists
amisulpride
amisulpride
dopamine antagonists
quetiapine
olanzapine
Selective Serotonin Reuptake Inhibitors
Olanzapine
Amisulpride
---
http://www.cochrane.org/fr/CD009043
2012
false
United Kingdom
France
French
Autism Spectrum Disorder
Aripiprazole
meta-analysis
treatment outcome
Autism spectrum disorder
antipsychotic agents
french abstract
---
http://www.cochrane.org/fr/CD006622
2011
false
true
false
France
United Kingdom
Aripiprazole
treatment outcome
meta-analysis
french abstract
placebos
schizophrenia
---
http://www.has-sante.fr/portail/jcms/c_991309/abilify-aripiprazole-antipsychotique
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-08/abilify_-_ct-_8227.pdf
http://www.has-sante.fr/portail/jcms/c_977226/abilify
2010
false
France
French
Aripiprazole
administration, oral
aripiprazole
antipsychotic agents
insurance, health, reimbursement
schizophrenia
adolescent
evaluation of the transparency committee
guidelines for drug use
---
http://www.cochrane.org/fr/CD006617
2010
false
true
false
France
United Kingdom
Aripiprazole
treatment outcome
review of literature
french abstract
schizophrenia
antipsychotic agents
---
http://www.has-sante.fr/portail/jcms/c_642494/abilify
http://www.has-sante.fr/portail/jcms/c_798068/abilify
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-05/abilify_-_ct-6282.pdf
2009
false
France
French
Aripiprazole
bipolar disorder
schizophrenia
psychomotor agitation
mental disorders
antipsychotic agents
injections, intramuscular
-
aripiprazole
insurance, health, reimbursement
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_756239/abilify
http://www.has-sante.fr/portail/jcms/c_400137/abilify
http://www.has-sante.fr/portail/jcms/c_818987/abilify-aripiprazole-antipsychotique-atypique
http://www.has-sante.fr/portail/jcms/c_756240/abilify-ct-5831
2009
false
France
French
Atypical antipsychotic (substance)
Aripiprazole
antipsychotic agents
bipolar disorder
aripiprazole
guidelines for drug use
evaluation of the transparency committee
---
Summary Basis of Decision (SBD) for ABILIFY
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00001
2009
false
Canada
English
French
Aripiprazole
Aripiprazole
schizophrenia
aripiprazole
antipsychotic agents
antipsychotic agents
treatment outcome
drug information
---
https://www.cadth.ca/sites/default/files/pdf/108_No28_aripiprazole_edrug_f.pdf
2002
false
Canada
French
Aripiprazole
antipsychotic agents
schizophrenia
clinical trials as topic
aripiprazole
drug evaluation
---